blog

DPharm 2018: A world where health records are no longer isolated.

By BBK Worldwide on Thu, Oct 18, 2018 | 1 min read

Pharma15 Live! sat down with David Levesque to discuss the goal and mission of Andaman7. Throughout the DPharm, one of the main topics was about new ways to allow patients to access their own data.

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

DPharm 2018: The Demands of DPharm Idol

By BBK Worldwide on Thu, Oct 11, 2018 | 1 min read

Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition:

Topics: Pharma15, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences

DPharm 2018: Who Owns Patient Data, and Who’s Just Visiting?

By BBK Worldwide on Wed, Oct 10, 2018 | 1 min read

What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.

Topics: Pharma15, Patient Experience, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences

When it Comes to Patient Data, Think First About the Patient

By BBK Worldwide on Thu, Aug 9, 2018 | 1 min read

 

Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.

Topics: patient data, clinical research, clinical trials, Pharma15

Agree or Disagree: We are Past the Era of Hype in Digital Health

By BBK Worldwide on Tue, Aug 7, 2018 | 1 min read

When it comes to digital health, do you believe that we are past the era of hype and into the era of adoption? Is there a degree of skepticism that still inhibits the wider adoption of digital health solutions in clinical research and healthcare?

Topics: digital health, Pharma15, Digital Platforms, Patient Recruitment

Maximizing Digital Patient Engagement: A Four Step Process

By BBK Worldwide on Thu, Aug 2, 2018 | 1 min read

The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.

Topics: Pharma15, Patient Experience, digital health, Patient Engagement, Vlog

Expert Take: Regulations aren’t an Excuse. Healthcare is Still Behind in Mobile Tech Adoption.

By BBK Worldwide on Tue, Jul 31, 2018 | 1 min read

Even when we consider the strict regulations inherent to the healthcare industry, we are still years behind where we should be with regard to the adoption of mobile health technologies. Just look to other highly regulated sectors, like banking and finance; we see that adoption of mobile technology in these industries is much more established.

Topics: Pharma15, mHealth, digital health

Amazon and PillPack: Disruptions and Innovations on the Horizon

By BBK Worldwide on Thu, Jul 26, 2018 | 1 min read

There is no doubt that Amazon’s recent acquisition of PillPack – the independent pharmacy and medication distribution system – has major implications not only for the clinical research industry, but the healthcare industry at-large. We asked BBK Worldwide president Matt Kibby to weigh in on Amazon’s foray into the pharmaceutical space. 

Topics: Pharma15, Vlog

Experts Debate: Is the Future Now for Mobile Technology and the Patient Experience?

By BBK Worldwide on Thu, Jul 12, 2018 | 1 min read

With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide founding principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?

Topics: Pharma15, Most Viewed

Agree or Disagree: Qualified Referrals Keep Sites Engaged

By BBK Worldwide on Wed, May 2, 2018 | 1 min read

 

While sites should be held accountable for processing the referrals that are generated from clinical trial advertising, it is very important that these referrals are qualified so that sites are not wasting their time. Therefore, generating highly qualified referrals is the number one contributing factor to site engagement.

Do you agree? Disagree? Watch the latest clip from our first episode of Pharma15 Live! and leave a comment below.

Topics: Pharma15

 
Subscribe To Our Blog